Amia Capital LLP Sangamo Therapeutics, Inc Transaction History

Amia Capital LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$9.23 - $18.18 $193,996 - $382,107	-21,018 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$9.38 - $12.48 $5,871 - $7,812	-626 Reduced 2.89%	21,018 $199,000
Q2 2020 Aug 14, 2020	SELL	$6.21 - $11.83 $73,967 - $140,907	-11,911 Reduced 35.5%	21,644 $194,000
Q1 2020 May 15, 2020	SELL	$5.05 - $8.85 $17,962 - $31,479	-3,557 Reduced 9.58%	33,555 $214,000
Q4 2019 Feb 13, 2020	BUY	$8.03 - $11.7 $298,009 - $434,210	37,112 New	37,112 $311,000

115

56.4M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $294M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Amia Capital LLP, based on Form 13F filings with the SEC.

Stay updated on Amia Capital LLP with notifications on news.